SPONSOR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Total Trials

Recruiting

Phases

Phase 1, Phase 2, EARLY_Phase 1

Conditions studied: Spinal Stenosis of Lumbar Region Spine Degeneration Cervical Cancer Ovarian Cancer Stage III Ovarian Cancer Stage IV Respiratory Failure Hypoxemic Respiratory Failure NET Radionucleide Therapy Contrast Enhanced Ultrasound

Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a clinical research sponsor with 39 registered studies on ClinicalTrials.gov, of which 39 are actively recruiting participants. Research covers conditions including Spinal Stenosis of Lumbar Region, Spine Degeneration, Cervical Cancer, Ovarian Cancer Stage III.

The trial portfolio spans Phase 1, Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Fondazione Policlinico Universitario Agostino Gemelli IRCCS

How many clinical trials has Fondazione Policlinico Universitario Agostino Gemelli IRCCS sponsored?

ClinicalMetric currently tracks 39 clinical trials sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS, of which 39 are actively recruiting participants. These trials cover conditions including Spinal Stenosis of Lumbar Region, Spine Degeneration, Cervical Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Fondazione Policlinico Universitario Agostino Gemelli IRCCS research focus on?

Fondazione Policlinico Universitario Agostino Gemelli IRCCS clinical trials span Spinal Stenosis of Lumbar Region, Spine Degeneration, Cervical Cancer, Ovarian Cancer Stage III, Ovarian Cancer Stage IV, and additional conditions. The research pipeline includes Phase 1, Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Fondazione Policlinico Universitario Agostino Gemelli IRCCS clinical trial?

To participate in a Fondazione Policlinico Universitario Agostino Gemelli IRCCS trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials with current recruitment status updated daily.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Frequently Asked Questions — Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Clinical Trials by Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Proteomic and Histological Analysis of Ligamentum Flavum in Lumbar Stenosis

Magnetic Resonance Fingerprinting for Preoperative Evaluation of Lymphovascular Space Invasion in Early Stage Cervical Cancer

Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer

Helmet NIV vs. CPAP vs. High-flow Nasal Oxygen in Hypoxemic Respiratory Failure

DCEUS to Assess Treatment Response to PRRT in GEP-NET

Efficacy of ABSOLOK™ Clip System-RFP-2021-01 in Open Liver Resection

Vortioxetine in Depression and Concomitant Migraine

Surgery for Male Stress Urinary Incontinence

Superdonor FMT in Patients With Ulcerative Colitis

Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.

Role of MRI Assessment in Fertility Sparing Treatment for Cervical Cancer at Staging and Follow-up and for Identification of Risk Factors for Aggressive Disease.

Tracheal Tube and Swallowing After Head and Neck Surgery

Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation

Paper-based Electrochemical Point-of-care Device in Diagnostic of Orthopedic Infections

New Procedure to Reduce Mother-newborn Separation

Delta Variation to Guide Hemodynamic Optimization

O2 Consumption And CO2 Production After Hemodynamic Optimization In Shock

Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma

The Management of Asymptomatic Carotid Stenosis

2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices

Genomic Profiling of Genetic and Rare Diseases

Endoscopic Injection of Autologous, Activated and Emulsified Fat in Chronic Fistulas of the Gastrointestinal Tract and Pelvic Organs

Pushing Using Real-time Sonographic Ultrasound Education

Surgical and Obstetric Outcomes in Patients With Uterine Malformations Undergoing Hysteroscopic Corrective Treatment

Microbiome Testing for the Screening of Colorectal Cancer

High-frequency Ultrasound for Intraoperative Lymph Node Assessment in Gynecological Cancer: From Surgery to Radiomics

Proactive Hemodynamic Management During Cytoreductive Surgery and HIPEC

Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases

Short-term Fasting Compared to Free Diet on Ovarian Cancer Patients

Study of Thoracic Ultrasound As a Response to the Closure of Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants

Estimation of the Diaphragm Electrical Activity and Intercostal Thickening Fraction During Different Pattern of Mechanical Ventilation: PSV Versus NAVA

Longitudinal Study on Diaframmatic Ultrasound in FSHD Patients

Caring for Frail Patients Through Vaccination

3D Analysis of Palatal Morphology of Growing Patients Treated With Rapid Palatal Expander.

No-Stoma Policy in Advanced Ovarian Cancer Surgery

Superior Cervical Ganglion in Parkinson's Disease

Takotsubo Syndrome and Air Pollution

Minimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence

OSNA Versus Ultrastaging to Detect Sentinel Lymph Node Metastasis in Endometrial Cancer